Polymorphisms in the SNCA gene and the risk of synucleopathy
Annals of Clinical and Experimental Neurology · 03.04.2025 · 19 (1) · 43-52
DOI: 10.17816/acen.1220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Experimental Neurology, online erschienen am 03.04.2025. Verfasst von Natalia Yu. Abramycheva und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Synucleinopathies are mostly sporadic and multifactorial neurodegenerative disorders, which determines the involvement of various risk factors in their development. The polymorphic variants of the SNCA gene are considered as one of the predisposing genetic factors. Study aim: to evaluate the effect of the 16 single nucleotide polymorphisms (SNP) located in various regulatory regions of the SNCA gene on the risk of developing three main forms of synucleinopathy — PD, DBL, and MSA — in Russian cohort of patients. Materials and methods. The study included 73 PD patients, 46 MSA patients, 10 DLB patients, and 62 healthy volunteers. Genotyping of 16 SNPs of the SNCA gene was performed by direct Sanger sequencing on a capillary genetic analyzer. The Benjamini–Hochberg procedure was applied for multiple pairwise comparisons.
Results
A comparative case-control study showed that only one (rs11931074) of the 16 SNP analyzed was associated with PD: the minor T allele, located in the 3’-UTR region of the SNCA gene, increased the risk of PD (OR = 5.19; p 0.05 (Benjamini–Hochberg adjusted p = 0.6)). An association with MSA was found for 11 of 16 SNP. The minor allele of 5 SNP (rs2619364, rs2619363, rs2619362, rs2619361, rs181489) reduced the risk of the disease, while for 6 SNP (rs7687945, rs2301134, rs2301135, rs3756063, rs2736990, rs11931074) increased the risk. The Benjamini–Hochberg procedure neutralized the significance of only one of these associations (rs181489).
Conclusion
This study is the first to genotype a large group of polymorphisms located in various regulatory regions of the SNCA gene and to establish significant associations with the risk of developing one of the forms of synucleinopathies, MSA, in the Russian population.
Zitieren
APA
Abramycheva, N. Y., Karan, L. S., Protopopova, A. O., Minaev, I. V., Berdalina, I. A., Fedotova, E. Y., & Illarioshkin, S. N. (2025). Polymorphisms in the SNCA gene and the risk of synucleopathy. Annals of Clinical and Experimental Neurology, 19(1), 43-52. https://doi.org/10.17816/acen.1220
Vancouver
Abramycheva NY, Karan LS, Protopopova AO, Minaev IV, Berdalina IA, Fedotova EY, et al. Polymorphisms in the SNCA gene and the risk of synucleopathy. Annals of Clinical and Experimental Neurology. 2025;19(1):43-52. doi:10.17816/acen.1220
BibTeX
@article{Abramycheva2025,
author = {Abramycheva, Natalia Yu. and Karan, Ludmila S. and Protopopova, Anna O. and Minaev, Ivan V. and Berdalina, Irina A. and Fedotova, Ekaterina Yu. and Illarioshkin, Sergey N.},
title = {Polymorphisms in the SNCA gene and the risk of synucleopathy},
journal = {Annals of Clinical and Experimental Neurology},
year = {2025},
volume = {19},
number = {1},
pages = {43--52},
doi = {10.17816/acen.1220}
}
EUVIMED